| Tag | Content |
|---|
EnhancerAtlas ID | HS154-14177 |
Organism | Homo sapiens |
Tissue/cell | Osteoblast |
Coordinate | chr20:61199620-61201650 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| ZNF263 | MA0528.1 | chr20:61200022-61200043 | TTTCCCCTGCTCTCCTCCTTC | - | 6.16 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_56107 | chr20:61198087-61205520 | u87 | | SE_67621 | chr20:61198087-61205520 | u87 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH20I062601 | chr20 | 61198208 | 61204407 |
|
Enhancer Sequence | TGCAACTCGC AAAGCAGTTA CCGCGGCTGC TGTAGGCATC TGTGTCAGTT GGGGCTGGCA 60
TCTGAGCATT GTCTGTTCTC TTGAGGATGA TCACACCTTC CTAGTTTTGT GTCTATTGAG 120
TAATTTTGTT TTACGTCTGA GCACACCGTG TGGACTCTGG GTGCTGTCCT AGCCCTCGGG 180
GAACGTTGCT GTTTCCACTT TAGCAGCCAG GTTCATCCCA AACCCCACCT CTCTCAGTGT 240
GGTTCTCAAG ACCTTTGCTG GGTTGGCACT GCTGGGTGGC ACTGTGAGAC TTATGCGGAT 300
TCATGCACAG AATTAGGCAA TTGCCGTGTC CAGCCCTCCC CCTTCCGGGG TTCCGCCCCC 360
TCTCTTCCCT GGCTCTCCCC CTTCTAGGGT TCCGCCCCCT CTTTTCCCCT GCTCTCCTCC 420
TTCCAGGGTT CTGCCCCCTC TCTTCCCCCA CTCTCCCCCT TCTGGGGTTC TGCCCCCTCT 480
CTTCCCCGGC TCTCCCCCTT CCAGGGTTCC ACCCCTCTCT TCTTCCCCGG CTCTCCCCAT 540
TCTGGGGTTC CACCCCTTTC TTACCTGTAG GACTCCTTTT CCCAGGTTGG GGTTTCTATC 600
TGCGTTTTAG CTGCTTGTGT TGCCATGTGG ATCTGAGAGT GGGGCTTGCC CTCCAGACAA 660
AGCCACAAGG AGGAAACCAG AAACTCCACG GCAGGTCACT CCTCCAAGTT CCGCCTCCGC 720
CCTGCAGTCT CCTTACTTTG CAGGTCCTCA GTAGTTGTCT GTGTCTCATC CAGAGCTTGG 780
TCACAGTTAG GGGAGGGCTA GGCTAAGCCA TAGCAGGCTC GTGGATAAAA CGTCACCTCC 840
CTGGCTCTTT CCCAGGATTT CCTGGCAGAG GCCACATTTA TAAGCCATGC AGTGTAGTCA 900
CCTGCTGTGT GCCAGGCAGC AAGCGCCATT AGCCCGGGAG GTGGTGAACA GCTCCTGGGG 960
GCACCAGCCA GCACCGTCAC CGTTTGGCAG CGGAGGCTGC GGCCAGCTCC TTGTCAGGTG 1020
AATGTGCTGC ATGTTGATGC AACACCTTCC TCTTCTTGCC AACCCTGGGC CAATGTCCTC 1080
AGACACAGGC AGCAACGGAA GTGGCCACCT GCCCACCATG GCCTGGGGAG AAGGGGGAAG 1140
GGTCTGACTG GGGGAGCCTC AAGACTGTGC CACTTGCCCC AATCCCATGA GAGGCACCTG 1200
CTATGGCACC TCGAGCTGGG GCAGAAGGCC TGGAGCCCGT GCCTGGATGC TGCCCAGGAC 1260
TCTCAAGCTA GTCCAGTGGC CTTGGCTGCA AAGTCCTGCT CAGGCCCACG TTTCCCCAGT 1320
GCCTTGCCCA GCTCCAGAGG GAAGTGATTG ACCGCAGAGC CGATGAGCTC AGAGCCGGTG 1380
GTGGGCAGTC TGGCCGGATG GCGGTGACTC AGGGAAGCGG AGGGGCTCCC CCCACCCCGC 1440
TGCTGCTGCC CCCCGCGTCC CCCCCGCCTG CAGTAACTGA CAGGAAGGGG CGGGAGGCGG 1500
ATGGGCCGTG ACAGCTTAAT GGCTTCGGTT AAAGCATCCT CTGATCGTGC TGGCGCTGGG 1560
AGAGGCTCTG AGCTCGGGTG GCACTGCGGG CACTCTGGAC ACTGTCTCCG GCTGCCGCTG 1620
AGCTGGGAGG CTCCTTTCCA GCAGGCCACG CGGTCAGGGG CACCTCCTGC CGCAGCACCT 1680
GCCCAGCCCT CTGGGGACCA GAGTGAGCAA AGTGCTGGTG CTGGACCTGG CCACCGCCAG 1740
AGGCAAACAC AGTTGGCCAG ACCCAGGCCC CACCTGTTCA CGAGATGCCC CATCCCTTGG 1800
AGCCTCCAGG AGCCAGGGCA AGTGTGGAGG CAGGTGAGAC CCAGCGCCAG CGTTTGCTTC 1860
AACCAAAGAA CCACAGCAGA GCCGCTGGGG ACAGCTTGTT CAGCCAGTGC ATAATCAGTA 1920
CTCAGGATTG TGGCTGGTGC CCCTGGCAGA CTCAGCCCTA CGGGGATCGG CCCCCAGACG 1980
TGCCACAGCT TGGCCACTCT GCTCTGAGGA GCTGTCTGTG CCCAGCACGC 2030
|
